Reuter V - Search Results

1

Copy number and gene expression differences between African American and Caucasian American prostate cancer.

Rose AE, Satagopan JM, Oddoux C, Zhou Q, Xu R, Olshen AB, Yu JZ, Dash A, Jean-Gilles J, Reuter V, Gerald WL, Lee P, Osman I. Rose AE, et al. Among authors: reuter v. J Transl Med. 2010 Jul 22;8:70. doi: 10.1186/1479-5876-8-70. J Transl Med. 2010. PMID: 20649978 Free PMC article.

2

A recurring translocation, t(11;22)(p13;q11.2), characterizes intra-abdominal desmoplastic small round-cell tumors.

Rodriguez E, Sreekantaiah C, Gerald W, Reuter VE, Motzer RJ, Chaganti RS. Rodriguez E, et al. Among authors: reuter ve. Cancer Genet Cytogenet. 1993 Aug;69(1):17-21. doi: 10.1016/0165-4608(93)90105-u. Cancer Genet Cytogenet. 1993. PMID: 8374894

3

Analysis of p21WAF1/CIP1 in primary bladder tumors.

Lacombe L, Orlow I, Silver D, Gerald WL, Fair WR, Reuter VE, Cordon-Cardo C. Lacombe L, et al. Among authors: reuter ve. Oncol Res. 1996;8(10-11):409-14. Oncol Res. 1996. PMID: 9114433

4

Chromosome 16 in primary prostate cancer: a microsatellite analysis.

Osman I, Scher H, Dalbagni G, Reuter V, Zhang ZF, Cordon-Cardo C. Osman I, et al. Among authors: reuter v. Int J Cancer. 1997 May 16;71(4):580-4. doi: 10.1002/(sici)1097-0215(19970516)71:4<580::aid-ijc12>3.0.co;2-g. Int J Cancer. 1997. PMID: 9178811

5

The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer.

Kelly WK, Osman I, Reuter VE, Curley T, Heston WD, Nanus DM, Scher HI. Kelly WK, et al. Among authors: reuter ve. Clin Cancer Res. 2000 Mar;6(3):838-46. Clin Cancer Res. 2000. PMID: 10741705 Clinical Trial.

6

HER-2 profiling and targeting in prostate carcinoma.

Morris MJ, Reuter VE, Kelly WK, Slovin SF, Kenneson K, Verbel D, Osman I, Scher HI. Morris MJ, et al. Cancer. 2002 Feb 15;94(4):980-6. Cancer. 2002. PMID: 11920466 Free article. Clinical Trial.

7

Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.

LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, Gerald WL. LaTulippe E, et al. Among authors: reuter v. Cancer Res. 2002 Aug 1;62(15):4499-506. Cancer Res. 2002. PMID: 12154061

8

Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance.

Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, Reuter V, Gerald WL. Holzbeierlein J, et al. Among authors: reuter v. Am J Pathol. 2004 Jan;164(1):217-27. doi: 10.1016/S0002-9440(10)63112-4. Am J Pathol. 2004. PMID: 14695335 Free PMC article.

9

Gene expression-based classification of nonseminomatous male germ cell tumors.

Korkola JE, Houldsworth J, Dobrzynski D, Olshen AB, Reuter VE, Bosl GJ, Chaganti RS. Korkola JE, et al. Oncogene. 2005 Jul 28;24(32):5101-7. doi: 10.1038/sj.onc.1208694. Oncogene. 2005. PMID: 15870693

10

Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.

Stephenson AJ, Smith A, Kattan MW, Satagopan J, Reuter VE, Scardino PT, Gerald WL. Stephenson AJ, et al. Cancer. 2005 Jul 15;104(2):290-8. doi: 10.1002/cncr.21157. Cancer. 2005. PMID: 15948174 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

741 results

Search Page

Filters